Skip to content
The Nexus
DossierENTITY

tau

Coverage of tau in the Nexus archive.

Earliest in view: Jul 1 · 08:30 UTCMost recent: Jul 26 · 10:14 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 26 · 10:14 UTCSCIENCE DAILY
    A hidden Alzheimer’s tipping point may decide who gets dementia

    Scientists have identified a possible tipping point in Alzheimer’s-related brain changes that determines dementia onset. The brain’s immune cells’ response to plaques and tau may be key, offering a new target for treatments to enhance cognitive resilience.

  • HEALTHJul 20 · 16:31 UTCNEW SCIENTIST
    Inhaling high dose CO2 clears Alzheimer’s proteins from the brain

    Inhaling a high dose of carbon dioxide may remove amyloid and tau proteins linked to Alzheimer's disease by enhancing the brain's glymphatic system.

  • HEALTHJul 12 · 20:01 UTCSTAT NEWS
    STAT+: Tau in the spotlight at Alzheimer’s conference

    The article highlights the focus on Tau at the Alzheimer’s Association International Conference (AAIC) in London. It promotes a special report by STAT on dementia diagnostics, treatments, and care, offering a discounted price for conference attendees using the code 'AAIC'.

  • HEALTHJul 1 · 08:30 UTCSTAT NEWS
    STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watch

    STAT’s biotech scorecard for Q3 highlights key events for Amylyx Pharmaceuticals and Biogen. Amylyx will report Phase 3 results for avexitide in post-bariatric hypoglycemia, while Biogen will present detailed data from a mid-stage Alzheimer’s trial for diranersen on July 14.